Carboplatin Alternatives Compared
| Carboplatin | Paclitaxel | Avastin (bevacizumab) |
|
|---|
| Carboplatin | Paclitaxel | Avastin (bevacizumab) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ovarian Cancer, Cervical Cancer, Cancer. Carboplatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Kaposi's Sarcoma, Nasopharyngeal Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor. Paclitaxel... View more |
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Cervical Cancer, Fallopian Tube Cancer, Hepatocellular Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
||||||||||||||||||||||||
| More about Carboplatin | More about Paclitaxel | More about Avastin (bevacizumab) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Carboplatin has an average rating of 7.4 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
Paclitaxel has an average rating of 7.2 out of 10 from a total of 10 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 10% reported a negative effect. |
Avastin has an average rating of 7.5 out of 10 from a total of 30 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Carboplatin side effects |
View all Paclitaxel side effects |
View all Avastin side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Carboplatin prices |
View all Paclitaxel prices |
View all Avastin prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Carboplatin Novaplus |
N/A |
Other bevacizumab brands include: Alymsys, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
120 hours |
17.4 hours |
480 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 366 drugs are known to interact with Carboplatin:
|
A total of 523 drugs are known to interact with Paclitaxel:
|
A total of 50 drugs are known to interact with Avastin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
February 26, 2004 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.